Long term use of imatinib in patients with severe pulmonary arterial hypertension
H. A. Ghofrani, N. W. Morrell, M. M. Hoeper, H. Olschewski, A. J. Peacock, R. J. Barst, S. Shapiro, D. A. Quinn, S. Pascoe (Hannover, Germany; Cambridge, Glasgow, United Kingdom; Graz, Austria; New York, Los Angeles, Cambridge, United States Of America; Basel, Switzerland)
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. A. Ghofrani, N. W. Morrell, M. M. Hoeper, H. Olschewski, A. J. Peacock, R. J. Barst, S. Shapiro, D. A. Quinn, S. Pascoe (Hannover, Germany; Cambridge, Glasgow, United Kingdom; Graz, Austria; New York, Los Angeles, Cambridge, United States Of America; Basel, Switzerland). Long term use of imatinib in patients with severe pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 203
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: